GlassScriptPhysician profile
Jenny Wiggins-Smith
NPI 1255523114
$4,954.71
in general payments reported to CMS, 2019-2025
21 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $11.50 · 2021: $31.95 · 2022: $3,474 · 2023: $54.18 · 2024: $1,036 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746 · Travel and Lodging: $566 · Gift: $14.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.84 |
| Travel and Lodging | $565.95 |
| Gift | $14.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,110.80 | 2022-2024 | |
| Genmab U.S., INC. | $103.09 | 2024 | Tivdak |
| Myovant Sciences INC. | $102.60 | 2022 | |
| Abbvie INC. | $95.65 | 2019-2022 | |
| Daiichi Sankyo INC. | $70.12 | 2022 | |
| Biogen, INC. | $55.42 | 2025 | Zurzuvae |
| Organon LLC | $50.26 | 2021-2025 | Nexplanon, Jada System |
| Astellas Pharma US INC | $42.26 | 2025 | Veozah |
| Allergan, INC. | $40.13 | 2019 | |
| Innovation Technologies INC | $39.49 | 2023 | Irrisept |
| Millicent US INC | $38.51 | 2025 | Femlyv |
| Dexcom, INC. | $37.45 | 2023-2024 | Dexcom G6 Transmitter |
| Evofem Biosciences, INC. | $34.21 | 2022-2025 | Phexxi, Solosec, Phexx |
| Medical Device Business Services, INC. | $22.94 | 2024 | Stratafix |
| Shield Therapeutics INC | $22.55 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $17.86 | 2025 | The Cologuard Plus Collection Kit |
| Coopersurgical, INC. | $16.04 | 2022 | |
| Minerva Surgical, INC | $14.60 | 2024 | |
| Exeltis, USA INC. | $14.41 | 2025 | Slynd |
| Novo Nordisk INC | $13.34 | 2024 | Wegovy |
| Hologic Sales and Service, LLC | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Wiggins-Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.